Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases
Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases Candidate molecules have the potential to treat multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and systemic inflammatory …